BACKGROUND Although rapid diagnosis of Lyme disease is essential for effective treatment, there is concern about inappropriate testing. We conducted a prospective, cross-sectional survey of clinicians to assess the use and appropriateness of Lyme disease serologic tests (LDSTs).
INTRODUCTION
L yme disease is a multisystem tick-borne infection caused by the spirochete Borrelia burgdorferi. 1, 2 Erythema migrans, the characteristic expanding rash of early localized Lyme disease, is present in at least 80% of cases, and joint, neurologic, cardiac and other manifestations may develop. 3 In the absence of erythema migrans, antibodies to B burgdorferi are generally required to diagnose Lyme disease. 3, 4 Approximately 2.8 million Lyme disease serologic tests (LDSTs) are performed each year in the United States according to a 1995 estimate. 4 At $40 per test, a conservative fi gure, the annual direct medical expenditure for LDSTs would exceed $100 million.
There is persisting concern that LDSTs are used inappropriately by clinicians. [5] [6] [7] Early serologic testing based only on tick bite or potential exposure to ticks has low sensitivity and specifi city and is not recommended. 8 For patients who live in areas where Lyme disease is endemic, and who have erythema migrans, serologic testing is not routinely recommended. predictive value of serologic testing, and the negative predictive value of serologic testing of these patients is exceedingly low. 9, 10 To assess factors contributing to appropriate and inappropriate use of LDSTs, we conducted a prospective, cross-sectional survey of clinicians ordering LDSTs.
METHODS
We surveyed clinicians who submitted specimens for Lyme disease serologic testing (enzyme immunoassay or immunofl uorescence assay) to 2 large clinical reference laboratories in Wisconsin. Up to 30 consecutive tests per month were selected from each laboratory during October 1999 through September 2000. No more than 2 tests per clinician were sampled during the study.
Consenting clinicians or other providers with access to the medical record completed a standardized survey questionnaire by telephone. Data gathered pertained to clinician characteristics and clinical circumstances related to each test.
Tests were classifi ed as appropriate, inappropriate, or discretionary (indeterminate appropriateness) using clinical criteria based on published recommendations. 3, 4, [8] [9] [10] A test was defi ned as appropriate if the patient had any objective fi ndings consistent with disseminated Lyme disease, including joint, neurologic, or cardiac symptoms, such as arthritis, lymphocytic meningitis, cranial neuritis, or atrioventricular conduction defects. A test was defi ned as inappropriate if the patient was asymptomatic, had clinician-diagnosed erythema migrans, or was treated empirically with antibiotics, or the test was ordered as a test of cure (Table 1 ). Because evidencebased practice guidelines do not address Lyme disease testing for other clinical symptoms (eg, arthralgias, myalgias, malaise, or fatigue), the test was defi ned as discretionary if it met none of these criteria.
Associations were assessed using univariate unconditional logistic regression analysis with calculation of odds ratios (OR) and 95% confi dence intervals (CI). Variables associated with inappropriate tests (P ≤.10) were entered into a multivariate unconditional logistic regression model using forward stepwise selection, followed by backward elimination. Discretionary tests were excluded from this analysis. All reported P values are 2-sided and P ≤.05 was considered statistically signifi cant. Statistical analyses were done with SAS version 6.12 (SAS Institute, Cary, NC).
RESULTS
We sampled 408 LDST requests, and 356 (87%) survey questionnaires were completed; 250 clinicians completed 1 questionnaire, and 53 completed 2 questionnaires. Forty clinicians refused to participate, and 12 could not be reached.
Of the 356 LDST requests, 20% were classifi ed as appropriate, 27% inappropriate, and 53% discretionary. Reasons for classifying tests as inappropriate were not mutually exclusive and included absence of symptoms (55%), empiric antibiotic treatment (27%), test of cure (27%), and diagnosis of erythema migrans (24%). Stratifi ed by specialty, family physicians, internists, and emergency and urgent care physicians ordered 70% of all tests and 75% of inappropriate tests (Table 2) .
Patients initiated 27% of LDST requests (Table  2) . Factors associated with patient-initiated testing included submission by a general internist (adjusted odds ratio [AOR] 2.6, 95% CI, 1.4-4.8) and patient age of 40 years and older (AOR 2.2, 95% CI, 1.3-3.9).
Patient-initiated tests were more likely to be inappropriate than tests initiated by clinicians (Table 3) . Other characteristics signifi cantly associated with inappropriate tests by univariate analysis included known or suspected tick bite within 30 days of illness onset, test ordered by an emergency or urgent care physician, and test done during the summer. Patient referral from another clinician and patient hospitalization were associated with a reduced likelihood of inappropriate testing.
Two factors were independently associated with inappropriate testing in the multivariate analysis: known or suspected tick bite within 30 days of illness onset, and test ordered by an emergency or urgent care clinician ( Table 3 ). The reasons for inappropriate testing by emergency or urgent care physicians were not signifi cantly different from those for other physicians.
DISCUSSION
Our study results show that only 20% of LDST requests were appropriate, and at least 27% were inappropriate. Inappropriate Lyme disease serologic testing represents an ineffi cient use of health care resources and may con- tribute to both underdiagnosis (eg, negative serologic fi ndings in patients with erythema migrans) and overdiagnosis (eg, patients with nonspecifi c constitutional symptoms) of Lyme disease. 5, [11] [12] [13] False-positive tests can result in unnecessary antibiotic treatment, which in turn may be associated with adverse events and contribute to the spread of antimicrobial resistance. 14, 15 False-negative tests may result in delayed treatment and increase the risk of spirochete dissemination. 12 In this study, more than one half of the inappropriate tests were for asymptomatic patients. Compared with family physicians and internists, physicians in emergency or urgent care were signifi cantly more likely to order inappropriate tests. The reason for this fi nding is unclear, but we speculate that physicians in these settings may use testing as a temporizing measure, delaying fi nal treatment decisions until the patient can follow up with his or her primary care physician. A known or suspected preceding tick bite was also strongly associated with inappropriate testing, suggesting a need for more clinician education on the risk of Lyme disease after a tick bite. A controlled study has shown that single-dose doxycycline given prophylactically can reduce the risk of Lyme disease after tick attachment in an endemic region, 16 but there is no benefi t to serologic testing regardless of the treatment decision. Interventions should be focused on educating providers about indications for Lyme disease testing, particularly that the absence of symptoms with or without a known or suspected recent tick bite obviates the need for testing.
We found 53% of all tests could not be classifi ed as either appropriate or inappropriate based on published recommendations. The existing diagnostic guidelines base testing decisions on the pretest probability of Lyme disease as calculated by an expert panel. 4 From a practical standpoint, clinicians and others might have diffi culty calculating the pretest probability of Lyme disease; hence, the high proportion of discretionary tests.
We also found that patients requested a large number of tests, which is consistent with previous fi ndings. 6 Nearly 40% of these tests were inappropriate, although most inappropriate tests were initiated by physicians.
A limitation of this study is that clinical information was provided by clinicians without validation by medical record review, although respondents often used the medical record to complete the interview. In addition, Note: discretionary tests were excluded from this analysis.
sampling from 2 laboratories in Wisconsin might not be representative of all clinicians ordering LDSTs. We conclude that inappropriate Lyme disease serologic testing is common in Wisconsin, and patients initiate many of these tests. Expanded education for clinicians and patients about testing indications and contraindications may reduce the number of inappropriate LDST requests. Clarifi cation of existing testing guidelines is needed to promote optimal use of LDSTs. Funding support: Centers for Disease Control and Prevention (Atlanta, GA) cooperative agreement on applied research in emerging infections−tick-borne diseases (#UR8/CCU513366-01).
